Mice with controlled skin burns were studied using local and systemic BPC-157 preparations, alongside vehicle, untreated, and silver-sulfadiazine comparisons.
What the researchers measured
Skin strength and elongation, swelling, inflammation, epithelial coverage, collagen, and associated gastric lesions were assessed for up to 21 days.
How to read this evidence
Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.
Results in context
The findings involved a specific mouse burn model and experimental preparations. They cannot establish the performance of a commercial cream or clinical burn treatment.
What this does not establish
Animal wound outcomes cannot establish clinical burn treatment, formulation equivalence, or human safety.
Publication & source
Why this paper is included
The compound is a named subject of the publication title.
Publication indexing
Comparative Study · Journal Article
Indexed subjects
Administration, Topical · Analysis of Variance · Animals · Burns · Disease Models, Animal · Gastric Mucosa · Male · Mice · Mice, Inbred Strains · Ointments · Peptide Fragments · Probability · Proteins · Random Allocation · Severity of Illness Index · Stomach Diseases · Treatment Outcome · Wound Healing
Source checked
October 4, 2026. Years follow journal issues; online-first dates may differ.